Discovery of SLC16A9 and SLC22A1 as regulators of acylcarnitines associated with Alzheimers disease
If something sounds too good to be true, it's probably not true - and its always best to err on the side of caution
Importantly, the cardiovascular benefit appears to be independent of glycemic control and is observed across subgroups defined by age, sex, and BMI [113, 150]
These differences are meaningful but both formulations achieve clinically significant improvements in glycemic control
The brain adjusts its expectations, and the pull toward alcohol often softens with it
Long-Term Concerns and the Need for Research While most reported side effects are mild and transient, its important to acknowledge the potential long-term concerns raised in research